Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
MedWellAI Inc., through its subsidiary, develops, acquires, operates, and invests in businesses. It provides AI-driven healthcare and wellness solutions. The company also offers a B2B e-commerce platform for distributing pharmaceutical products, particularly GLP medications for weight loss and diabetes management. In addition, it provides an AI-powered ordering system with inventory tracking, smart suggestions, and support for healthcare providers such as wellness clinics, med spas, and corporate wellness facilities. The company was formerly known as Integrated Ventures, Inc. and changed its name to MedWellAI Inc. in June 2025. The company is based in Clearwater, Florida.
MedWell Ai, Inc Reports Q3 Revenues Of $618,676 And Provides Corporate Update
MedWell Ai reported Q3 revenue of $618,676, more than doubling the $281,318 generated in the prior year, while significantly narrowing its net loss.
For the nine months ended March 31, 2026, revenue reached $1.69 million versus $425,327 a year ago, driven by its B2B pharma procurement arm MedWell USA.
The company reconfirmed its annual revenue guidance of $2.3 million and announced it is preparing for Phase 2 restructuring, including strategic acquisitions to form a vertically integrated wellness roll-up.